Search Results - "Erali, Richard A"

Epidemiology of Pediatric Fractures Presenting to Emergency Departments in the United States by Naranje, Sameer M, Erali, Richard A, Warner, William C, Sawyer, Jeffrey R, Kelly, Derek M

“…BACKGROUND:Fractures in children are an important public health issue and a frequent cause of emergency room visits. The purpose of this descriptive…”
Get full text

Organoid Platform in Preclinical Investigation of Personalized Immunotherapy Efficacy in Appendiceal Cancer: Feasibility Study by Forsythe, Steven D, Erali, Richard A, Sasikumar, Shyama, Laney, Preston, Shelkey, Ethan, D'Agostino, Jr, Ralph, Miller, Lance D, Shen, Perry, Levine, Edward A, Soker, Shay, Votanopoulos, Konstantinos I

“…Immunotherapy efficacy data on appendiceal cancer from clinical trials does not exist, due to appendiceal cancer incidence of 0.97 per 100,000. The goal of…”
Get full text

Application of immune enhanced organoids in modeling personalized Merkel cell carcinoma research by Forsythe, Steven D., Erali, Richard A., Laney, Preston, Sivakumar, Hemamylammal, Li, Wencheng, Skardal, Aleksander, Soker, Shay, Votanopoulos, Konstantinos I.

“…Merkel cell carcinoma (MCC) is a rare neuroendocrine cutaneous cancer, with incidence of less than 1/100,000, low survival rates and variable response to…”
Get full text

Long-Term Survival in Patients Treated with Cytoreduction and Heated Intraperitoneal Chemotherapy for Peritoneal Mesothelioma at a Single High-Volume Center by Valenzuela, Cristian D., Solsky, Ian B., Erali, Richard A., Forsythe, Steven D., Mangieri, Christopher W., Mainali, Bigyan B., Russell, Gregory, Perry, Kathleen C., Votanopoulos, Konstantinos I., Shen, Perry, Levine, Edward A.

“…Background Malignant peritoneal mesothelioma (MPM) is a rare diagnosis with a dismal prognosis if untreated. Cytoreductive surgery with hyperthermic…”
Get full text

Cisplatin exhibits superiority over MMC as a perfusion agent in a peritoneal mesothelioma patient specific organoid HIPEC platform by Forsythe, Steven D., Erali, Richard A., Edenhoffer, Nicholas, Meeker, William, Wajih, Nadeem, Schaaf, Cecilia R., Laney, Preston, Vanezuela, Cristian D., Li, Wencheng, Levine, Edward A., Soker, Shay, Votanopoulos, Konstantinos I.

“…Peritoneal mesothelioma (PM) is a rare malignancy with poor prognosis, representing about 10–15% of all mesothelioma cases. Herein we apply PM patient-derived…”
Get full text

ASO Author Reflections: Innovative HIPEC Organoid Models and Mucolytics: Targeted Therapeutic Use of Bromelain for Appendiceal Cancer by Erali, Richard A., Wajih, Nadeem, Morris, David L., Votanopoulos, Konstantinos I.

Get full text

Patient-Specific Sarcoma Organoids for Personalized Translational Research: Unification of the Operating Room with Rare Cancer Research and Clinical Implications by Forsythe, Steven D., Sivakumar, Hemamylammal, Erali, Richard A., Wajih, Nadeem, Li, Wencheng, Shen, Perry, Levine, Edward A., Miller, Katherine E., Skardal, Aleksander, Votanopoulos, Konstantinos I.

“…Introduction Sarcoma clinical outcomes have been stagnant for decades due to heterogeneity of primaries, lack of comprehensive preclinical models, and rarity…”
Get full text

Prognostic Effect of Aberrant Right Hepatic Artery with Pancreaticoduodenectomy: Focus on Hepatic Recurrence by Mangieri, Christopher W., Valenzuela, Cristian D., Erali, Richard A., Shen, Perry, Howerton, Russell, Clark, Clancy J.

“…Introduction Metastatic progression occurs along the locoregional vasculature, and a common anatomic variant is an aberrant right hepatic artery (aRHA). This…”
Get full text

ASO Author Reflections: Sarcoma Organoids: Neutralizing the Word “Rare” in Rare Cancers by Forsythe, Steven D., Sivakumar, Hemamylammal, Erali, Richard A., Skardal, Aleksander, Votanopoulos, Konstantinos I.

Get full text

ASO Visual Abstract: Prognostic Effect of Aberrant Right Hepatic Artery with Pancreaticoduodenectomy—Focus on Hepatic Recurrence by Mangieri, Christopher W., Valenzuela, Cristian D., Erali, Richard A., Shen, Perry, Howerton, Russell, Clark, Clancy J.

Get full text

Switching Perfusion Agents for Repeat Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy: Surgical Dogma or Evidence-Based Practice? by Mangieri, Christopher W., Valenzuela, Cristian D., Solsky, Ian B., Erali, Richard A., Votanopoulos, Konstantinos I., Shen, Perry, Levine, Edward A.

“…Background A common practice is to switch chemotherapy perfusion agents for repeat cytoreductive surgery with hyperthermic intraperitoneal chemotherapy…”
Get full text

Utility of Neoadjuvant Chemotherapy for Peritoneal Carcinomatosis Secondary to High-Grade Appendiceal Neoplasms for Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy by Mangieri, Christopher W., Moaven, Omeed, Valenzuela, Cristian D., Erali, Richard A., Votanopoulos, Konstantinos I., Shen, Perry, Levine, Edward A.

“…Introduction Neoadjuvant chemotherapy (NAT) is frequently utilized before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) for…”
Get full text

Exposure to Neoadjuvant Oxaliplatin-Containing Chemotherapy, Does it Effect Intraperitoneal Hyperthermic Chemotherapy Perfusion? by Mangieri, Christopher W., Valenzuela, Cristian D., Solsky, Ian B., Erali, Richard A., Votanopoulos, Konstantinos I., Shen, Perry, Levine, Edward A.

“…Introduction Patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) are commonly exposed to oxaliplatin…”
Get full text

ASO Visual Abstract: Exposure to Neoadjuvant Oxaliplatin-Containing Chemotherapy; Does It Affect Intraperitoneal Hyperthermic Chemotherapy Perfusion? by Mangieri, Christopher W., Valenzuela, Cristian D., Solsky, Ian B., Erali, Richard A., Votanopoulos, Konstantinos I., Shen, Perry, Levine, Edward A.

Get full text

Enhancing the Efficacy of HIPEC Through Bromelain: A Preclinical Investigation in Appendiceal Cancer by Wajih, Nadeem, Erali, Richard A., Forsythe, Steven D., Schaaf, Cecilia R., Shen, Perry, Levine, Edward A., Soker, Shay, Morris, David L., Votanopoulos, Konstantinos I.

“…Introduction Appendiceal cancer (AC) excessive mucin production is a barrier to heated intraperitoneal chemotherapy (HIPEC) drug delivery. Bromelain is a…”
Get full text

High-risk liver patients are not associated with adverse events following pancreaticoduodenectomy by Mangieri, Christopher W., Strode, Matthew A., Valenzuela, Cristian D., Erali, Richard A., Shen, Perry, Howerton, Russell, Clark, Clancy J.

“…Pancreaticoduodenectomy performed with underlying hepatic disease has been reported to have increased adverse events postoperatively. This study aimed to…”
Get full text

Effect of preoperative liver-directed therapy prior to hepatic resection by Mangieri, Christopher W., Valenzuela, Cristian D., Strode, Matthew A., Erali, Richard A., Shen, Perry, Howerton, Russell, Clark, Clancy J.

“…Hepatobiliary malignancies present with advanced disease precluding upfront resection. Liver-directed therapy (LDT), particularly Y-90 radioembolization and…”
Get full text

ASO Visual Abstract: Switching Perfusion Agents for Repeat Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy, Surgical Dogma or Evidence-Based Practice? by Mangieri, Christopher W., Valenzuela, Cristian D., Solsky, Ian B., Erali, Richard A., Votanopoulos, Konstantinos I., Shen, Perry, Levine, Edward A.

Get full text

ASO Visual Abstract: Enhancing the Efficacy of HIPEC Through Bromelain: A Preclinical Investigation in Appendiceal Cancer by Wajih, Nadeem, Erali, Richard A., Forsythe, Steven D., Schaaf, Cecilia R., Shen, Perry, Levine, Edward A., Soker, Shay, Morris, David L., Votanopoulos, Konstantinos I.

Get full text

Incidence, Risk Factors, and Outcomes from Conversion of Low-Grade to High-Grade Appendiceal Neoplasms for Patients Undergoing Multiple Cytoreductive Surgeries with Hyperthermic Intraperitoneal Chemotherapy by Mangieri, Christopher W., Valenzuela, Cristian D., Erali, Richard A., Votanopoulos, Konstantinos I., Shen, Perry, Levine, Edward A.

“…Introduction Conversion from low-grade to high-grade disease is known to occur following repeat cytoreductive surgery and hyperthermic intraperitoneal…”
Get full text